Idiopathic Pulmonary Fibrosis and Lung Cancer: A Systematic Review and Meta-Analysis.
暂无分享,去创建一个
P. Boffetta | J. Wisnivesky | D. Hashim | M. Padilla | Stacey-Ann Whittaker Brown | M. Agovino | Molly Dobelle
[1] M. YektaKooshali,et al. Lung cancer in idiopathic pulmonary fibrosis: A systematic review and meta-analysis , 2018, PloS one.
[2] Yanhong Ren,et al. Incidence and radiologic‐pathological features of lung cancer in idiopathic pulmonary fibrosis , 2018, The clinical respiratory journal.
[3] A. Gemma,et al. Reduced incidence of lung cancer in patients with idiopathic pulmonary fibrosis treated with pirfenidone. , 2018, Respiratory investigation.
[4] S. Matsuda,et al. Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis. , 2018, Respiratory investigation.
[5] Ruchi Bansal,et al. Drug targeting to myofibroblasts: Implications for fibrosis and cancer , 2017, Advanced drug delivery reviews.
[6] Demosthenes Bouros,et al. Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice” , 2017, Front. Med..
[7] Hanna M. Nurmi,et al. Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis , 2017, Respiratory Research.
[8] Vasilis Aidinis,et al. Lung cancer in patients with idiopathic pulmonary fibrosis. , 2017, Pulmonary pharmacology & therapeutics.
[9] J. Ruiz-manzano,et al. Lung Cancer in Patients With Combined Pulmonary Fibrosis and Emphysema and Idiopathic Pulmonary Fibrosis. A Descriptive Study in a Spanish Series. , 2017, Archivos de bronconeumologia.
[10] H. Collard,et al. Code‐based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis. Case Validation and Improvement , 2017, Annals of the American Thoracic Society.
[11] H. Asamura,et al. Clinicopathological, Immunohistochemical, and Genetic Features of Primary Lung Adenocarcinoma Occurring in the Setting of Usual Interstitial Pneumonia Pattern , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[12] M. Tanahashi,et al. Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer , 2016, Cancer Chemotherapy and Pharmacology.
[13] A. Warth,et al. Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis , 2016, PloS one.
[14] Asger Dirksen,et al. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling. , 2016, American journal of respiratory and critical care medicine.
[15] S. Nathan,et al. Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation. , 2015, American journal of respiratory and critical care medicine.
[16] C. Vancheri,et al. Idiopathic pulmonary fibrosis and lung cancer: a clinical and pathogenesis update , 2015, Current opinion in pulmonary medicine.
[17] N. Inui,et al. Impact of Preexisting Interstitial Lung Disease on Acute, Extensive Radiation Pneumonitis: Retrospective Analysis of Patients with Lung Cancer , 2015, PloS one.
[18] G. Raghu,et al. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review , 2015, European Respiratory Journal.
[19] K. Yoh,et al. Efficacy and Safety of Combined Carboplatin, Paclitaxel, and Bevacizumab for Patients with Advanced Non-squamous Non-small Cell Lung Cancer with Pre-existing Interstitial Lung Disease: A Retrospective Multi-institutional Study. , 2015, Anticancer research.
[20] J. Yim,et al. Validation of the GAP score in Korean patients with idiopathic pulmonary fibrosis. , 2015, Chest.
[21] V. Poletti,et al. The impact of lung cancer on survival of idiopathic pulmonary fibrosis. , 2015, Chest.
[22] R. Sussman,et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.
[23] H. Collard,et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.
[24] O. Hilberg,et al. How does comorbidity influence survival in idiopathic pulmonary fibrosis? , 2014, Respiratory Medicine.
[25] C. Park,et al. Lung cancer risk among patients with combined pulmonary fibrosis and emphysema. , 2014, Respiratory medicine.
[26] Jae Ho Lee,et al. Lung cancer in patients with idiopathic pulmonary fibrosis: clinical characteristics and impact on survival. , 2013, Respiratory medicine.
[27] Carlo Vancheri,et al. Common pathways in idiopathic pulmonary fibrosis and cancer , 2013, European Respiratory Review.
[28] Ping Li,et al. Serum miR-21 and miR-155 expression in idiopathic pulmonary fibrosis , 2013, The Journal of asthma : official journal of the Association for the Care of Asthma.
[29] M. Mascalchi,et al. Four-Year Results of Low-Dose CT Screening and Nodule Management in the ITALUNG Trial , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[30] T. Higami,et al. Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis , 2013, General Thoracic and Cardiovascular Surgery.
[31] Luba Nalysnyk,et al. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature , 2012, European Respiratory Review.
[32] Y. Kondoh,et al. Efficacy of Chemotherapy for Advanced Non-Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis , 2012, Respiration.
[33] Ugo Pastorino,et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[34] Choon-Sik Park,et al. Prevalence, risk factors and survival of lung cancer in the idiopathic pulmonary fibrosis , 2012, Thoracic Cancer.
[35] Li Zhang,et al. Clinical characteristics of patients with lung cancer and idiopathic pulmonary fibrosis in China , 2011, Thoracic cancer.
[36] Y. Kawabata,et al. Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis. , 2011, The Annals of thoracic surgery.
[37] Luca Richeldi,et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. , 2011, The New England journal of medicine.
[38] C. Gatsonis,et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .
[39] S. Sahn,et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials , 2011, The Lancet.
[40] Takeshi Johkoh,et al. American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .
[41] D. Schroeder,et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. , 2010, Chest.
[42] I. D. Johnston,et al. Cryptogenic fibrosing alveolitis and lung cancer: the BTS study , 2009, Thorax.
[43] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.
[44] K. Chida,et al. Cumulative incidence of and predictive factors for lung cancer in IPF , 2009, Respirology.
[45] R. Hubbard,et al. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. , 2007, Respiratory medicine.
[46] M. Mishima,et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. , 2007, Chest.
[47] J. Hagood,et al. Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts. , 2007, American journal of respiratory cell and molecular biology.
[48] P. Brennan,et al. High cumulative risk of lung cancer death among smokers and nonsmokers in Central and Eastern Europe. , 2006, American journal of epidemiology.
[49] M. Chung,et al. Prognostic factors and causes of death in Korean patients with idiopathic pulmonary fibrosis. , 2006, Respiratory medicine.
[50] S. Kudoh,et al. Occupational and Environmental Factors and Idiopathic Pulmonary Fibrosis in Japan , 2005 .
[51] John Connett,et al. The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality , 2005, Annals of Internal Medicine.
[52] M. Sawabe,et al. A clinical study of idiopathic pulmonary fibrosis based on autopsy studies in elderly patients. , 2003, Internal medicine.
[53] S. Sakai,et al. Lung Cancer Associated With Diffuse Pulmonary Fibrosis: CT–Pathologic Correlation , 2003, Journal of thoracic imaging.
[54] F. Martinez,et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications , 2003, Thorax.
[55] V. Pankratz,et al. Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis. , 2002, Mayo Clinic proceedings.
[56] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[57] T. Kuroki,et al. Hyperplastic epithelial foci in honeycomb lesions in idiopathic pulmonary fibrosis , 2002, Virchows Archiv.
[58] T. Shim,et al. Lung cancer in patients with idiopathic pulmonary fibrosis. , 2001, The European respiratory journal.
[59] Richard Doll,et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies , 2000, BMJ : British Medical Journal.
[60] R. Hubbard,et al. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. , 2000, American journal of respiratory and critical care medicine.
[61] David A. Lynch,et al. Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .
[62] M. Fukayama,et al. Pulmonary fibrosis and lung carcinoma: A comparative study of metaplastic epithelia in honeycombed areas of usual interstitial pneumonia with or without lung carcinoma , 1999, Pathology international.
[63] M. Kitaichi,et al. Hospital-based historical cohort study of 234 histologically proven Japanese patients with IPF. , 1999, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[64] J. M. Harris,et al. Does cryptogenic fibrosing alveolitis carry an increased risk of death from lung cancer? , 1998, Journal of epidemiology and community health.
[65] J A Waldron,et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. , 1997, American journal of respiratory and critical care medicine.
[66] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[67] J. Im,et al. Lung cancer in patients with idiopathic pulmonary fibrosis: CT findings. , 1996, Journal of computer assisted tomography.
[68] D. Mannino,et al. Pulmonary Fibrosis and Lung Cancer in the United States: Analysis of the Multiple Cause of Death Mortality Data, 1979 Through 1991 , 1996, Southern medical journal.
[69] M. Hara,et al. Iung cancer associated with usual interstitial pneumonia , 1995, Pathology international.
[70] A. Nagai,et al. Lung cancer in patients with idiopathic pulmonary fibrosis. , 1992, The Tohoku journal of experimental medicine.
[71] A Whitehead,et al. A general parametric approach to the meta-analysis of randomized clinical trials. , 1991, Statistics in medicine.
[72] M. Lebowitz,et al. Cryptogenic fibrosing alveolitis and lung cancer. , 1980, Thorax.